Connection
Thomas Flaig to Interleukin-2
This is a "connection" page, showing publications Thomas Flaig has written about Interleukin-2.
|
|
Connection Strength |
|
|
|
|
|
0.113 |
|
|
|
-
Lam ET, Wong MK, Agarwal N, Redman BG, Logan T, Gao D, Flaig TW, Lewis K, Poust J, Monk P, Jarkowski A, Sendilnathan A, Bolden M, Kuzel TM, Olencki T. Retrospective analysis of the safety and efficacy of high-dose interleukin-2 after prior tyrosine kinase inhibitor therapy in patients with advanced renal cell carcinoma. J Immunother. 2014 Sep; 37(7):360-5.
Score: 0.113